Cargando…
Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review
[Image: see text] OBJECTIVES: The amyotrophic lateral sclerosis (ALS) research community was one of the first to adopt methodology guidelines to improve preclinical research reproducibility. We here present the results of a systematic review to investigate how the standards in this field changed ove...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715942/ https://www.ncbi.nlm.nih.gov/pubmed/35047680 http://dx.doi.org/10.1136/bmjos-2018-000016 |
_version_ | 1784624224107757568 |
---|---|
author | Fernandes, Joana G Franco, Nuno H Grierson, Andrew J Hultgren, Jan Furley, Andrew J W Olsson, I Anna S |
author_facet | Fernandes, Joana G Franco, Nuno H Grierson, Andrew J Hultgren, Jan Furley, Andrew J W Olsson, I Anna S |
author_sort | Fernandes, Joana G |
collection | PubMed |
description | [Image: see text] OBJECTIVES: The amyotrophic lateral sclerosis (ALS) research community was one of the first to adopt methodology guidelines to improve preclinical research reproducibility. We here present the results of a systematic review to investigate how the standards in this field changed over the 10-year period during which the guidelines were first published (2007) and updated (2010). METHODS: We searched for papers reporting ALS research on SOD1 (superoxide dismutase 1) mice published between 2005 and 2015 on the ISI Web of Science database, resulting in a sample of 569 papers to review, after triage. Two scores—one for methodological quality, one for regulatory compliance—were built from weighted sums of separate sets of items, and subjected to multivariable regression analysis, to assess how these related to publication year, type of study, country of origin and journal. RESULTS: Reporting standards improved over time. Of papers published after the first ALS guidelines were made public, fewer than 9% referred specifically to these. Of key research parameters, only three (genetic background, number of transgenes and group size) were reported in >50% of the papers. Information on housing conditions, randomisation and blinding was absent in over two-thirds of the papers. Group size was among the best reported parameters, but the majority reported using fewer than the recommended sample size and only two studies clearly justified group size. CONCLUSIONS: General methodological standards improved gradually over a period of 8–10 years, but remained generally comparable with related fields with no specific guidelines, except with regard to severity. Only 11% of ALS studies were classified in the highest severity level (animals allowed to reach death or moribund stages), substantially below the proportion in studies of comparable neurodegenerative diseases such as Huntington’s. The existence of field-specific guidelines, although a welcome indication of concern, seems insufficient to ensure adherence to high methodological standards. Other mechanisms may be required to improve methodological and welfare standards. |
format | Online Article Text |
id | pubmed-8715942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87159422022-01-18 Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review Fernandes, Joana G Franco, Nuno H Grierson, Andrew J Hultgren, Jan Furley, Andrew J W Olsson, I Anna S BMJ Open Sci Research [Image: see text] OBJECTIVES: The amyotrophic lateral sclerosis (ALS) research community was one of the first to adopt methodology guidelines to improve preclinical research reproducibility. We here present the results of a systematic review to investigate how the standards in this field changed over the 10-year period during which the guidelines were first published (2007) and updated (2010). METHODS: We searched for papers reporting ALS research on SOD1 (superoxide dismutase 1) mice published between 2005 and 2015 on the ISI Web of Science database, resulting in a sample of 569 papers to review, after triage. Two scores—one for methodological quality, one for regulatory compliance—were built from weighted sums of separate sets of items, and subjected to multivariable regression analysis, to assess how these related to publication year, type of study, country of origin and journal. RESULTS: Reporting standards improved over time. Of papers published after the first ALS guidelines were made public, fewer than 9% referred specifically to these. Of key research parameters, only three (genetic background, number of transgenes and group size) were reported in >50% of the papers. Information on housing conditions, randomisation and blinding was absent in over two-thirds of the papers. Group size was among the best reported parameters, but the majority reported using fewer than the recommended sample size and only two studies clearly justified group size. CONCLUSIONS: General methodological standards improved gradually over a period of 8–10 years, but remained generally comparable with related fields with no specific guidelines, except with regard to severity. Only 11% of ALS studies were classified in the highest severity level (animals allowed to reach death or moribund stages), substantially below the proportion in studies of comparable neurodegenerative diseases such as Huntington’s. The existence of field-specific guidelines, although a welcome indication of concern, seems insufficient to ensure adherence to high methodological standards. Other mechanisms may be required to improve methodological and welfare standards. BMJ Publishing Group 2019-08-01 /pmc/articles/PMC8715942/ /pubmed/35047680 http://dx.doi.org/10.1136/bmjos-2018-000016 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Fernandes, Joana G Franco, Nuno H Grierson, Andrew J Hultgren, Jan Furley, Andrew J W Olsson, I Anna S Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review |
title | Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review |
title_full | Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review |
title_fullStr | Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review |
title_full_unstemmed | Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review |
title_short | Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review |
title_sort | methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715942/ https://www.ncbi.nlm.nih.gov/pubmed/35047680 http://dx.doi.org/10.1136/bmjos-2018-000016 |
work_keys_str_mv | AT fernandesjoanag methodologicalstandardsqualityofreportingandregulatorycomplianceinanimalresearchonamyotrophiclateralsclerosisasystematicreview AT franconunoh methodologicalstandardsqualityofreportingandregulatorycomplianceinanimalresearchonamyotrophiclateralsclerosisasystematicreview AT griersonandrewj methodologicalstandardsqualityofreportingandregulatorycomplianceinanimalresearchonamyotrophiclateralsclerosisasystematicreview AT hultgrenjan methodologicalstandardsqualityofreportingandregulatorycomplianceinanimalresearchonamyotrophiclateralsclerosisasystematicreview AT furleyandrewjw methodologicalstandardsqualityofreportingandregulatorycomplianceinanimalresearchonamyotrophiclateralsclerosisasystematicreview AT olssoniannas methodologicalstandardsqualityofreportingandregulatorycomplianceinanimalresearchonamyotrophiclateralsclerosisasystematicreview |